Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
6.93
+0.11 (1.61%)
At close: Jun 26, 2026, 4:00 PM EDT
6.86
-0.07 (-1.01%)
After-hours: Jun 26, 2026, 5:51 PM EDT
Turn Therapeutics Market Cap
Turn Therapeutics has a market cap or net worth of $206.43 million as of June 26, 2026.
Market Cap
206.43M
Enterprise Value
201.22M
1-Year Change
n/a
Ranking
Category
Stock Price
$6.93
Market Cap Chart
Since October 8, 2025, Turn Therapeutics's market cap has increased from $196.16M to $206.43M, an increase of 5.24%. That is a compound annual growth rate of 7.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 206.43M | 77.94% |
| Dec 31, 2025 | 116.01M | -40.86% |
| Oct 8, 2025 | 196.16M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Keros Therapeutics | 205.84M |
| Nkarta | 204.62M |
| Unicycive Therapeutics | 202.65M |
| NervGen Pharma | 200.72M |
| Arcturus Therapeutics Holdings | 200.10M |
| Canton Strategic Holdings | 199.99M |
| Oramed Pharmaceuticals | 199.29M |
| Cellectis | 199.19M |